Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 3 | $6,678,053 |
Sells | 63 | $306,127,850 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 22 Dec 2022 | Sale | 3,284,800 | 21.71 | 71,313,008 | I |
27 Dec 2022 17:32 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 22 Dec 2022 | Sale | 3,284,800 | 21.71 | 71,313,008 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 23 Dec 2022 | Sale | 1,116,048 | 23.23 | 25,925,795 | I |
27 Dec 2022 17:32 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 23 Dec 2022 | Sale | 1,116,048 | 23.23 | 25,925,795 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 23 Dec 2022 | Sale | 961,328 | 22.27 | 21,408,775 | I |
27 Dec 2022 17:32 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 23 Dec 2022 | Sale | 961,328 | 22.27 | 21,408,775 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 22 Dec 2022 | Sale | 684,696 | 22.07 | 15,111,241 | I |
27 Dec 2022 17:32 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 22 Dec 2022 | Sale | 684,696 | 22.07 | 15,111,241 | I |
15 May 2023 18:06 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 15 May 2023 | Sale | 345,313 | 20 | 6,906,260 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 15 May 2023 | Sale | 345,313 | 20 | 6,906,260 | I |
17 Aug 2022 16:03 | VRNA | Verona Pharma plc | ACCESS INDUSTRIES HOLDINGS LLC | 10% | 15 Aug 2022 | Purchase | 4,800,000 | 1.3125 | 6,300,000 | I |
27 Dec 2022 17:38 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 23 Dec 2022 | Sale | 92,992 | 24.11 | 2,242,037 | I |
27 Dec 2022 17:32 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 23 Dec 2022 | Sale | 92,992 | 24.11 | 2,242,037 | I |
15 May 2023 18:06 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 11 May 2023 | Sale | 80,000 | 22.26 | 1,780,800 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 11 May 2023 | Sale | 80,000 | 22.26 | 1,780,800 | I |
21 Dec 2022 16:06 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 20 Dec 2022 | Sale | 600,000 | 2.116 | 1,269,600 | D |
21 Dec 2022 16:05 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 20 Dec 2022 | Sale | 600,000 | 2.1151 | 1,269,060 | D |
03 May 2023 19:46 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 01 May 2023 | Sale | 455,536 | 2.5759 | 1,173,415 | D |
03 May 2023 19:48 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 May 2023 | Sale | 455,528 | 2.5759 | 1,173,395 | D |
03 Feb 2023 18:18 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 01 Feb 2023 | Sale | 432,928 | 2.5572 | 1,107,083 | D |
03 Feb 2023 18:19 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 Feb 2023 | Sale | 413,168 | 2.5572 | 1,056,553 | D |
11 Aug 2022 21:45 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 09 Aug 2022 | Sale | 600,000 | 1.75 | 1,050,000 | D |
11 Aug 2022 21:46 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 09 Aug 2022 | Sale | 600,000 | 1.75 | 1,050,000 | D |
15 May 2023 18:06 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 12 May 2023 | Sale | 43,200 | 21.64 | 934,848 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 12 May 2023 | Sale | 43,200 | 21.64 | 934,848 | I |
27 Dec 2022 18:50 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 22 Dec 2022 | Sale | 240,000 | 2.6918 | 646,032 | I |
03 Feb 2023 18:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 01 Feb 2023 | Sale | 152,000 | 2.5939 | 394,273 | I |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 04 Aug 2023 | Sale | 150,000 | 2.4992 | 374,880 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 04 Aug 2023 | Sale | 150,000 | 2.4992 | 374,880 | D |
15 May 2023 18:06 | VRNA | Verona Pharma plc | GUPTA RISHI | Director | 15 May 2023 | Sale | 14,400 | 21.96 | 316,224 | I |
15 May 2023 18:07 | VRNA | Verona Pharma plc | ORBIMED ADVISORS LLC | Director | 15 May 2023 | Sale | 14,400 | 21.96 | 316,224 | I |
08 Nov 2023 16:15 | VRNA | Verona Pharma plc | EBSWORTH DAVID R | Director | 06 Nov 2023 | Purchase | 160,000 | 1.9755 | 316,080 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 03 Aug 2023 | Sale | 117,272 | 2.539 | 297,754 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 03 Aug 2023 | Sale | 117,272 | 2.539 | 297,754 | D |
03 Aug 2023 20:31 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 Aug 2023 | Sale | 105,944 | 2.679 | 283,824 | D |
03 Aug 2023 20:29 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 01 Aug 2023 | Sale | 105,944 | 2.679 | 283,824 | D |
03 Feb 2023 18:17 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 01 Feb 2023 | Sale | 89,960 | 2.5572 | 230,046 | D |
03 May 2023 19:49 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 01 May 2023 | Sale | 80,376 | 2.5759 | 207,041 | D |
03 May 2023 19:49 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 01 May 2023 | Sale | 77,424 | 2.5759 | 199,436 | D |
03 Aug 2023 20:31 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 02 Aug 2023 | Sale | 73,704 | 2.593 | 191,114 | D |
03 Aug 2023 20:29 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 02 Aug 2023 | Sale | 73,704 | 2.593 | 191,114 | D |
03 Nov 2023 20:11 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Nov 2023 | Sale | 58,752 | 1.92 | 112,804 | D |
05 Feb 2024 18:11 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 05 Feb 2024 | Sale | 36,248 | 2.2209 | 80,503 | D |
03 May 2023 19:49 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 May 2023 | Sale | 28,752 | 2.6517 | 76,242 | D |
07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Aug 2023 | Sale | 28,752 | 2.55 | 73,318 | D |
03 Feb 2023 18:17 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 02 Feb 2023 | Sale | 28,752 | 2.528 | 72,685 | D |
03 May 2024 19:21 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 May 2024 | Sale | 36,248 | 1.9596 | 71,032 | D |
07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 04 Aug 2023 | Sale | 27,944 | 2.4992 | 69,838 | D |
07 Aug 2023 21:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 04 Aug 2023 | Sale | 26,352 | 2.4992 | 65,859 | D |
22 Nov 2023 17:09 | VRNA | Verona Pharma plc | EDWARDS MARTIN | Director | 20 Nov 2023 | Purchase | 33,736 | 1.837 | 61,973 | D |
07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 03 Aug 2023 | Sale | 21,848 | 2.539 | 55,472 | D |
03 Nov 2022 16:06 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 01 Nov 2022 | Sale | 32,904 | 1.6726 | 55,035 | D |
03 Aug 2023 20:27 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 01 Aug 2023 | Sale | 19,736 | 2.679 | 52,873 | D |
07 Aug 2023 21:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 03 Aug 2023 | Sale | 20,608 | 2.539 | 52,324 | D |
03 Aug 2023 20:30 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 01 Aug 2023 | Sale | 18,608 | 2.679 | 49,851 | D |
03 Nov 2022 16:05 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 01 Nov 2022 | Sale | 28,752 | 1.639 | 47,125 | D |
03 Aug 2023 20:27 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 02 Aug 2023 | Sale | 13,728 | 2.593 | 35,597 | D |
03 Aug 2023 20:30 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 02 Aug 2023 | Sale | 12,944 | 2.593 | 33,564 | D |
03 Aug 2022 16:12 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 01 Aug 2022 | Sale | 32,904 | 0.6998 | 23,026 | D |
03 Nov 2022 16:05 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 Nov 2022 | Sale | 13,160 | 1.6726 | 22,011 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 07 Aug 2023 | Sale | 8,616 | 2.4679 | 21,263 | D |
07 Aug 2023 21:17 | VRNA | Verona Pharma plc | ZACCARDELLI DAVID | President and CEO | 07 Aug 2023 | Sale | 8,616 | 2.4679 | 21,263 | D |
03 Aug 2022 16:11 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 02 Aug 2022 | Sale | 28,752 | 0.7031 | 20,216 | D |
03 Aug 2022 16:10 | VRNA | Verona Pharma plc | HAHN MARK W | Chief Financial Officer | 01 Aug 2022 | Sale | 13,168 | 0.6998 | 9,215 | D |
07 Aug 2023 21:19 | VRNA | Verona Pharma plc | RICKARD KATHLEEN A. | Chief Medical Officer | 07 Aug 2023 | Sale | 1,600 | 2.4679 | 3,949 | D |
07 Aug 2023 21:15 | VRNA | Verona Pharma plc | POLL CLAIRE | General Counsel | 07 Aug 2023 | Sale | 1,512 | 2.4679 | 3,731 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)